CancerCareTM
- VDxI completed the pilot study for a new biomarker for the detection of common canine malignancies. The data was presented as an oral abstract
presentation at the recent Veterinary Cancer Symposium on November 2, 2007.
Data will also be presented at the 2008 ACVIM Annual Conference. CancerCare will be available in 2008.
|
CartilageCareTM
- VDxI has identified and validated a unique biomarker to be used to diagnose canine, feline and equine arthritis. CartilageCare will be available 1st quarter 2008.
|
RenalCareTM
- VDxI has identified and validated a biomarker to assess canine and feline kidney function. RenalCare will be used
in conjuntion with all VDxI proprietary assays in order to more accurately report assay results in dogs and cats with concurrent renal disease.
RenalCare will be available in 2008.
|
SepsisCareTM
- VDxI has identified and validated a unique biomarker to assist in diagnosing sepsis in cats and dogs.
|
Equine CardioCareTM
- Equine CardioCare is a simple blood test to detect heart disease and heart failure in horses. The test detects levels of equine NT-proBNP. Scheduled release date is 2nd quarter 2008.
|
Products & Services
